Found: 17
Select item for more details and to access through your institution.
Adherence, Persistence, Switching and Costs of Injectable and Oral Therapies for Multiple Sclerosis. Real Life Analysis Over 6 Years of Treatment.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 4, p. 476, doi. 10.1177/00185787241232615
- By:
- Publication type:
- Article
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 519, doi. 10.1007/s00228-024-03628-2
- By:
- Publication type:
- Article
Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 2, p. 165, doi. 10.1177/00185787231196763
- By:
- Publication type:
- Article
Antidepressant deprescribing: State of the art and recommendations—A literature overview.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 3, p. 417, doi. 10.1007/s00228-023-03617-x
- By:
- Publication type:
- Article
Real-World Effectiveness of Calcitonin Gene--Related Peptide-Binding Monoclonal Antibodies for Migraine Prevention: A Systematic Review.
- Published in:
- Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière, 2024, v. 77, n. 1, p. 1, doi. 10.4212/cjhp.3382
- By:
- Publication type:
- Article
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 8, p. 1806, doi. 10.1177/10781552221117135
- By:
- Publication type:
- Article
Buone pratiche per lo sviluppo dei modelli di budget impact a livello regionale.
- Published in:
- Global & Regional Health Technology Assessment, 2023, v. 10, n. 1, p. 53, doi. 10.33393/grhta.2023.2582
- By:
- Publication type:
- Article
Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 83, doi. 10.1177/10781552211053251
- By:
- Publication type:
- Article
Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological Therapies.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5167, doi. 10.3390/cancers14205167
- By:
- Publication type:
- Article
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 870, doi. 10.1177/10781552211005518
- By:
- Publication type:
- Article
Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 5, p. 1999, doi. 10.1111/bcp.15147
- By:
- Publication type:
- Article
Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 24, doi. 10.1177/1078155220980807
- By:
- Publication type:
- Article
Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 6, p. 843, doi. 10.1007/s00228-020-02850-y
- By:
- Publication type:
- Article
Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 5, p. 1035, doi. 10.1177/1078155218759184
- By:
- Publication type:
- Article
Dosage adjustments in pivotal clinical trials with oral targeted therapies in solid tumors conducted in Europe.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 697, doi. 10.1007/s00228-018-02621-w
- By:
- Publication type:
- Article
Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
- Published in:
- Acta Haematologica, 2016, v. 136, n. 1, p. 45, doi. 10.1159/000444626
- By:
- Publication type:
- Article
Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056813
- By:
- Publication type:
- Article